Connect with us

Caribbean News

CARPHA Urges Member States to e Vigilant Following WHO Declaration of a Public Health Emergency of International Concern for Mpox

Published

on

Port of Spain, Trinidad and Tobago. 16 August 2024.   Mpox was declared a public health emergency of international concern (PHEIC) on 14 August 2024 by the World Health Organization (WHO) following an upsurge of infections by the virus in the Democratic Republic of the Congo and a growing number of countries in Africa.

This is the highest level of global alert recognizing the potential threat this virus poses to countries around the world, and it is the second declaration in two years of a PHEIC relating to mpox.  This current outbreak of mpox is caused by clade I, which is more transmissible and causes more severe illness. Clade II was responsible for an outbreak that WHO declared to be a global health emergency from July 2022 to May 2023.

Presently, no cases of clade 1b mpox have been reported in the Caribbean and its neighbouring countries including the United States, United Kingdom, Canada, and Latin America. There is also a limited number of travellers and no direct commercial flights from the Democratic Republic of Congo, or its neighbouring countries to the Caribbean.

“CARPHA is monitoring the situation closely. The current risk to Caribbean population from mpox clade 1b is low to moderate, as no cases of mpox have been identified in the CARPHA Member States. However, the identification of the first case of clade 1b outside of Africa, is a warning call for public health authorities to be vigilant and necessitates enhanced surveillance by all Caribbean countries, inclusive of monitoring of incoming passengers, and rapid/early identification of potential cases, and a well-coordinated regional and international response,” states Dr Lisa Indar, Ad Interim Executive Director at the Caribbean Public Health Agency (CARPHA).

Mpox, formerly known as monkeypox, is a viral disease that can spread easily between people and from infected animals. It can spread through direct contact with bodily fluids, such as during sex, and through contaminated materials like sheets, and clothing used by an infected person.  Common symptoms of mpox are a skin rash or mucosal lesions which can last 2–4 weeks accompanied by fever, headache, muscle aches, back pain, low energy, and swollen lymph nodes.

Currently, two mpox vaccines have been approved by the WHO-listed national regulatory authorities and the process has been started for Emergency Use Listing which improves the capacity for vaccine distribution to low-resourced areas and countries.

“Mpox virus testing capacity has been established at the CARPHA Medical Microbiology Laboratory.  Additionally, CARPHA is collaborating with regional public health partners to respond to any surge in mpox cases in the Region. Additionally, we are liaising with CARICOM Implementation Agency for Crime and Security (IMPACS) for Advanced Passenger information for persons arriving from countries that have reported mpox,” said Dr Horace Cox, Acting Director of Surveillance, Disease Control and Prevention at CARPHA.

CARPHA issued a watching brief on mpox to Member States and recommends enhanced vigilance, including the following measures to its Member States: Act quickly and transparently, and report, if any imported cases of mpox are identified; Enhance surveillance systems for rapid identification of imported cases presenting with fever and rash; enhance case investigation for mpox, including alerting port health officials to be vigilant for possible cases; develop and disseminate public education materials on mpox as a re-emerging zoonosis.

Additionally, Member States are encouraged to promote awareness among clinicians, other frontline health workers and public health professionals to be alert to persons presenting with rash without a clear alternative diagnosis, particularly with a travel history from countries that have reported mpox, within two weeks preceding the onset of signs and symptoms are urged to promote comprehensive mpox prevention and control strategies for high-risk populations. CARPHA will provide Member States with guidance to support their national response efforts.

To reduce exposure to and transmission of the virus, persons should maintain basic hand hygiene – wash hands frequently with soap and water or an alcohol-based hand sanitiser.  In addition,

  • Stay informed about the risk of mpox
  • Be on the alert for any unusual rashes or lesions on the genitals or other parts of the body
  • Avoid close contact with people who are sick with signs and symptoms of mpox, including those with skin lesions or genital lesions.
  • Avoid contact with wild animals (alive or dead) in areas where mpox regularly occurs.
  • Avoid contact with contaminated materials used by people who are sick (such as clothing, bedding, or materials used in healthcare settings).

Caribbean News

ENTITIES STRENGTHEN COLLABORATION TO FIGHT GENDER-BASED VIOLENCE

Published

on

Kingston, Jamaica, December 3, 2024 – The Women’s Resource and Outreach Centre (WROC) is strengthening its partnership with key stakeholders to prevent Gender-Based Violence (GBV), and support young women and girls in vulnerable communities.

Under an agreement, which was signed on Tuesday (November 19) during a Gender-Based Violence Prevention Network (GBVPN) event at the Terra Nova All-Suite Hotel in Kingston, the stakeholders, which include public and private sector entities, will collaborate to carry out activities geared towards responding to and preventing gender-based violence in vulnerable communities.

One key aspect of the arrangement is the provision of assistance through the WROC’s GBVPN facility.

Community members will be able to engage with civil society organisations, as well as public and private institutions, to discuss the gender-based violence issues they face. They will also receive support in seeking remedies for their situations.

Executive Director of the WROC, Keisha Williams, explained that the GBVPN, which was launched in 2021, aims to create a people-centred approach and provide real-time support and advocacy for survivors of gender-based violence.

She said through the network, the WROC has secured partnerships with over 15 organisations and implemented case management and referral systems for survivors.

“We have provided trauma informed care counselling for many of our community members and implemented a robust case management system for survivors,” she added.

The Executive Director also lauded the partnership with the Inter-American Foundation (IAF), including a grant from the organisation, which “has helped WROC enhance its impact on communities by expanding advocacy efforts in the fight against GBV.”

 

She noted that the grant focused on three key components – institutional strengthening, creation of a gender-based violence prevention network and small business development.

Founded in 1983, the WROC works to improve collaboration among institutions that work to prevent gender and family violence, strengthen communities’ ability to reduce violence, and support survivors.

The organisation provides outreach programmes, with a focus on health and wellness, sustainable livelihoods, community capacity-building and advocacy.

Among its key stakeholders are: the Bureau of Gender Affairs (BGA), Child Protection and Family Services Agency (CPFSA),Women’s Empowerment Benevolent Society (WEBS), Social Development Commission (SDC), Fight for Peace, Trench Town Community Development Committee, Centre for Investigation of Sexual Offences and Child Abuse (CISOCA), Calvary Temple Church, Bethel New Testament Church, Jamaicans for Justice (JFJ) and the Rose Town Foundation.

 

CONTACT: E. HARTMAN RECKORD

RELEASE: JIS

Continue Reading

Caribbean News

CARPHA Hosts Regional IATA Infectious Substances Transport “Train-the-Trainer” Workshop with the Pandemic Fund’s Support

Published

on

Port of Spain, Trinidad and Tobago – The Caribbean Public Health Agency (CARPHA) concluded its Train-the-Trainer Workshop on the Safe Transportation of Infectious Substances today. The workshop, conducted by the International Air Transport Association (IATA), was supported by the Pandemic Fund grant, with CARPHA serving as the Executing Agency and the Inter-American Development Bank (IDB) as the Implementing Entity.

Fourteen (14) CARPHA Member States (CMS) participated in this initiative, which aimed to strengthen regional capacity to meet international safety standards for shipping infectious substances. The training provided participants with essential theoretical knowledge, interactive discussions, and practical exercises to achieve IATA certification as trainers. These certified trainers will now be well-positioned to serve as national trainers and advisors in biosafety and safe transport protocols, ensuring safer practices across the region.

Dr. Lisa Indar, Ad. Interim Executive Director of CARPHA, highlighted the significance of the initiative: “As a region, we must ensure that the transportation of infectious substances meets international safety standards to protect our public health systems and communities. This workshop builds on CARPHA’s commitment to developing a robust network of certified trainers who can implement and sustain best practices in their home countries. We are grateful for the training supported by the Pandemic Fund project, enabling us to take key steps in pandemic preparedness and response.”

The program not only addressed gaps in Certified Infectious Substance Transport Training within CMS, but also established mechanisms for monitoring and evaluating the trainers’ impact in their respective countries. Participants are expected to conduct infectious substances transport training within the first quarter of 2025, ensuring the rapid application of their certification.

Speaking at the opening ceremony, Dr. Horace Cox, Acting Director of Surveillance, Disease Prevention and Control at CARPHA, remarked: “The effectiveness of our public health response hinges on having a cadre of professionals who can translate this critical knowledge into action at the country level. This program empowers Member States to strengthen their capacity to handle infectious substances safely and securely, which is a cornerstone in bolstering regional health systems and pandemic preparedness and response.”

To ensure the sustainability of the training program, CARPHA is also establishing mechanisms for ongoing feedback and continuous improvement, ensuring that the program remains dynamic and responsive to the needs of the Member States and trainees. These efforts promise to enable better tracking of training activities and contribute to the long-term sustainability of the training program. This initiative is part of CARPHA’s broader mission to enhance laboratory capabilities, improve surveillance systems, and ensure public health security across the Caribbean. By creating a robust network of self-sufficient trainers in its Member States, CARPHA aims to strengthen the capacity for safely shipping infectious substances and enhance regional public health resilience.

About the Pandemic Fund Project:

The Caribbean Public Health Agency (CARPHA), the sole regional public health agency, is the Executing Agency for the Pandemic Fund (PF) Project: RG-T4387, with the Inter-American Development Bank (IDB) as the Implementing Entity. The goal of this Project, which spans from 2024 to 2026, is to Reduce the Public Health Impact of Pandemics in the Caribbean through Prevention, Preparedness, and Response (PPR). The objective is to support the reduction of the public health impact of pandemics in the Caribbean by building pandemic PPR surveillance and early warning systems, laboratory systems and workforce capacity, regionally at CARPHA and at country levels. This will reduce the transboundary spread of infectious diseases and improve regional and global health security. CARPHA is the beneficiary of the PF project and CARPHA Member States are the participants.

The PF was approved at the highest level by the Council for Human and Social Development, as well as by CARPHA’s Executive Board and other stakeholders, including Chief Medical Officers. This is a regional 3-year project (2024-2026). The public signing of Technical Cooperation Agreement to implement the project was on December 14, 2023.

Continue Reading

Caribbean News

Eight Regional countries pick up new INFECTION; now OROPOUCHE VIRUS caught in Cayman and DR

Published

on

Garfield Ekon

Staff Writer

 

 

Cayman Islands, December 3, 2024 – Local health and mosquito-control officials have confirmed the Cayman Islands’ first imported case of Oropouche virus disease.

This discovery has sparked calls for the public to strengthen their defences against vector-borne diseases. The Oropouche virus, which spreads to humans through bites from Culicoides paraensis midges (a type of small fly) and Culex mosquitoes, has previously been reported in South America and some Caribbean countries, according to the World Health Organization (WHO).

While there is no evidence of community transmission in the Cayman Islands, authorities have also confirmed multiple imported cases of dengue fever this year. “Vector-borne diseases are a reminder of how connected we are as a region. By staying alert and taking simple precautions, we can protect ourselves and our community from the risks these diseases pose,” he stated.

The announcement comes amid a broader regional uptick in Oropouche virus cases. This month, Panama reported its first locally transmitted human case, with similar outbreaks documented in Brazil, Bolivia, Colombia, Peru, Cuba, Guyana, and the Dominican Republic.

“Outbreaks of vector-borne diseases, including Oropouche and Dengue, underscore the importance of public awareness and action,” said Rachel Corbett, national epidemiologist for the Ministry of Health. “Travelers from affected regions like Cuba and Panama should use personal protective measures and monitor for symptoms such as fever or rash upon their return,” she said.

The Cayman Islands’ Mosquito Research and Control Unit (MRCU) assured the public that it remains proactive in its efforts to curb mosquito populations and mitigate the risk of disease spread.

Jonathan Smellie, Molecular Biology Laboratory Manager, highlighted the country’s preparedness, stating, “Our ability to test locally for both the Oropouche and dengue viruses ensures timely diagnosis and a swift public health response.”

Continue Reading

FIND US ON FACEBOOK

TRENDING